4//SEC Filing
Schall Thomas J. 4
Accession 0001415889-24-007651
CIK 0001790340other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:02 PM ET
Size
5.4 KB
Accession
0001415889-24-007651
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Schall Thomas J.
Director
Transactions
- Award
Stock Option
2024-03-11+35,000→ 35,000 totalExercise: $5.93Exp: 2034-03-11→ Class A Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a three year period commencing on April 11, 2024, and will be fully vested and exercisable on March 11, 2027.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001423084
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 5:02 PM ET
- Size
- 5.4 KB